Barinthus Biotherapeutics (BRNS) Net Cash Flow Growth (3y) (2023 - 2026)
Barinthus Biotherapeutics (BRNS) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 89.97% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -13.44% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 33.37% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 6.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.04% |
| Dec 31, 2025 | 28.18% |
| Sep 30, 2025 | -44.89% |
| Jun 30, 2025 | -20.20% |
| Mar 31, 2025 | -23.93% |
| Dec 31, 2024 | 38.85% |
| Sep 30, 2024 | -71.58% |
| Jun 30, 2024 | -28.77% |
| Mar 31, 2024 | -28.11% |
| Dec 31, 2023 | -54.64% |
| Sep 30, 2023 | -132.38% |
| Jun 30, 2023 | -171.59% |
| Mar 31, 2023 | 2.77% |